CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer

被引:0
作者
Jianjie Zhu
Tingting Cai
Jieqi Zhou
Wenwen Du
Yuanyuan Zeng
Ting Liu
Yulong Fu
Yue Li
Qian Qian
Xiuwei H. Yang
Qinglin Li
Jian-an Huang
Zeyi Liu
机构
[1] the First Affiliated Hospital of Soochow University,Department of Pulmonary and Critical Care Medicine
[2] Soochow University,Institute of Respiratory Diseases
[3] Suzhou Key Laboratory for Respiratory Diseases,Department of Medicine, Division of Allergy and Clinical Immunology
[4] National Jewish Health,Department of Pharmacology and Nutritional Sciences, Department of Molecular and Cellular Biochemistry, Markey Cancer Center
[5] University of Kentucky,Department of Traditional Chinese Medicine
[6] Cancer Hospital of the University of Chinese Academy of Sciences,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 40卷
关键词
CD151; Integrins; EGFR/ErbB2; Proliferation; NSCLC;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer
    Zhu, Jianjie
    Cai, Tingting
    Zhou, Jieqi
    Du, Wenwen
    Zeng, Yuanyuan
    Liu, Ting
    Fu, Yulong
    Li, Yue
    Qian, Qian
    Yang, Xiuwei H.
    Li, Qinglin
    Huang, Jian-An
    Liu, Zeyi
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [2] Extracellular fibrin promotes non-small cell lung cancer progression through integrin ß1/PTEN/AKT signaling
    Li, Guilong
    Cai, Jiaying
    Xie, Jianjun
    Dai, Yizhi
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [3] Integrin-associated CD151 is a suppressor of prostate cancer progression
    Han, Rongbo
    Hensley, Patrick J.
    Li, Jieming
    Zhang, Yang
    Stark, Timothy W.
    Heller, Allie
    Qian, Hai
    Shi, Junfeng
    Liu, Zeyi
    Huang, Jian-An
    Jin, Tengchuan
    Wei, Xiaowei
    Zhou, Binhua P.
    Wu, Yadi
    Kyprianou, Natasha
    Chen, Jinfei
    Yang, Xiuwei H.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (04): : 1428 - 1442
  • [4] Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR
    Zhang, Xiao-Wei
    Li, Lin
    Hu, Wen-Qian
    Hu, Ming-Ning
    Tao, Yan
    Hu, Hui
    Miao, Xiao-Kang
    Yang, Wen-Le
    Zhu, Qiong
    Mou, Ling-Yun
    CELL DEATH & DISEASE, 2022, 13 (01)
  • [5] PFTK1 promotes the progression of non-small cell lung cancer (NSCLC) through the Wnt/β-catenin signaling pathway
    Jia, Liang-Liang
    Chen, Jie
    Gai, Ling
    Li, Yu-Peng
    Lu, Xiao-Ning
    Cui, Xue-Fan
    Ji, Li-Li
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (12): : 12228 - 12239
  • [6] Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR
    Sun, Yuxiao
    Gao, Yu
    Dong, Mingxin
    Li, Jiuzhen
    Li, Xin
    He, Ningning
    Song, Huijuan
    Zhang, Manman
    Ji, Kaihua
    Wang, Jinhan
    Gu, Yeqing
    Wang, Yan
    Du, Liqing
    Liu, Yang
    Wang, Qin
    Zhai, Hezheng
    Sun, Daqiang
    Liu, Qiang
    Xu, Chang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [7] Hydroxygenkwanin Suppresses Non-Small Cell Lung Cancer Progression by Enhancing EGFR Degradation
    Leu, Yann-Lii
    Wang, Tong-Hong
    Wu, Chih-Ching
    Huang, Kuo-Yen
    Jiang, Yu-Wen
    Hsu, Yi-Chiung
    Chen, Chi-Yuan
    MOLECULES, 2020, 25 (04):
  • [8] Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling
    Zhao, Huanyu
    Sun, Jian
    Shao, Jianshuang
    Zou, Zifang
    Qiu, Xueshan
    Wang, Enhua
    Wu, Guangping
    JOURNAL OF CANCER, 2019, 10 (20): : 4989 - 4997
  • [9] Amplification of USP13 drives non-small cell lung cancer progression mediated by AKT/MAPK signaling
    Wu, Yue
    Zhang, Yingqiu
    Liu, Congcong
    Zhang, Yang
    Wang, Duchuang
    Wang, Shanshan
    Wu, Yueguang
    Liu, Fang
    Li, Qiong
    Liu, Xiuxiu
    Zaky, Mohamed Y.
    Yan, Dong
    Liu, Shuyan
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [10] Integrin-α5 expression and its role in non-small cell lung cancer progression
    Ka, Mirei
    Matsumoto, Yoko
    Ando, Takahiro
    Hinata, Munetoshi
    Xi, Qian
    Sugiura, Yuriko
    Iida, Takahiro
    Nakagawa, Natsuki
    Tokunaga, Masakatsu
    Watanabe, Kousuke
    Kawakami, Masanori
    Ushiku, Tetsuo
    Sato, Masaaki
    Oda, Katsutoshi
    Kage, Hidenori
    CANCER SCIENCE, 2024, : 406 - 419